ChipsJuly 20, 2026via NVIDIA Blog
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
Why it matters
Pharma's AI infrastructure arms race is accelerating. BMS's doubling down on enterprise-scale GPU clusters signals that computational capacity—not just models—is becoming the competitive moat in drug discovery and biotech R&D.
Key signals
- Bristol Myers Squibb deploying second NVIDIA DGX SuperPOD
- Built on NVIDIA Vera Rubin architecture
- BMS already runs one of the largest AI clusters in life sciences
- Named 'SuperDuperPOD' internally
- Infrastructure play in pharma/life sciences sector
The hook
Not a pilot. Bristol Myers Squibb just deployed its second NVIDIA SuperPOD—the life sciences industry's largest AI compute cluster.
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. And they’re doubling down. BMS announced today it is deploying its second NVIDIA …